Blume-Jensen Peter sold ACRV
February 14, 2026 · Form 4 insider transaction
Blume-Jensen Peter sold 1,302 shares of Acrivon Therapeutics, Inc. at $1.63 per share, a transaction worth $2.1K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,302
Price
$1.63
Total value
$2.1K
InsiderBlume-Jensen Peter
RoleOfficer, Director
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 14, 2026
Filing dateFebruary 18, 2026
Shares owned after2,094,469
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.; These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson?s spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.